Observed on 23 JUL
ID 621-628-LR26
Micronized progesterone 200 mg
CENABAST · Procurement Unit 621
Open, single-stage process subject to Chilean public procurement controls.
View official notice ↗Santiago, ChileInternational editionEvidence for regulatory decisions
Pharmaceutical industry intelligence
Dose Dumping
Chile · Regulation · Industry
Published by SERTURNERVisit the regulatory firm →
The Chile regulatory desk
Understand the structure before committing the portfolio.
Independent, source-led explanations for pharmaceutical companies evaluating product registration, a local marketing authorization holder, public procurement or an operating structure in Chile.
Edition 01 · Public procurement snapshot
Tenders observed at the July editorial close
A dated market snapshot for manufacturers, importers, distributors and specialized logistics operators. For current opportunities, use the official platform and the CENABAST guide below.
Read the practical CENABAST tender guide →
Observed on 23 JUL
ID 1211839-47-LR26
Backup supply agreement for CENABAST disruptions
Puente Alto Primary Care Network
Contingency contract covering shortages, delays or failures in supply.
View official notice ↗Observed on 23 JUL
ID 564953-59-LR26
Logistics operator for pharmaceutical products
Las Condes Education and Health Corporation
Receipt, storage, order preparation and distribution of pharmaceutical products.
View official notice ↗Observed on 23 JUL
ID 1058085-124-LR26
Nivolumab supply when CENABAST cannot deliver
Hospital del Salvador
A 36-month backup agreement intended to protect continuity of supply.
View official notice ↗Historical status verified on 23 July 2026. These deadlines have passed and are retained as the Edition 01 record. Always search Mercado Público for current notices.
Practical guides for international companies
Six decisions to resolve before operating or bidding in Chile
English-language, pharmaceutical-focused guidance grounded in Chilean primary sources and written for regulatory, operational and business teams.
017 min
Registration
How to Register a Pharmaceutical Product in Chile
The authority structure, dossier baseline, admissibility, evaluation and lifecycle responsibilities international teams need to understand.
Read guide →026 min
Holder & lifecycle
When Does a Foreign Company Need a Local MA Holder in Chile?
What holder acceptance really means and why due diligence, interfaces and exit arrangements matter.
Read guide →037 min
Dossier readiness
Common CTD Dossier Gaps Before a Submission in Chile
Five recurring consistency problems across product identity, manufacturing, analytical, stability and local documentation.
Read guide →046 min
Portfolio strategy
Regulatory Routes for a Pharmaceutical Portfolio Entering Chile
How to separate dossier, sequencing, holder and operating-model decisions without confusing regulatory work with commercialization.
Read guide →056 min
Company setup
Setting Up a Pharmaceutical Company in Chile: Four Regulatory Layers
A coordinated view of the legal vehicle, tax activation, regulatory readiness and sanitary authorizations.
Read guide →069 min
Public procurement
A Practical Guide to CENABAST Public Tenders
How pharmaceutical suppliers can assess eligibility, product fit, bid viability, tender documents and post-award execution in Chile.
Read guide →Current regulatory signals
What international teams need translated clearly
Short analytical notes linking international search language with the competent Chilean authority and operating reality.
A Ministry of Health search should lead to the correct Chilean authority
Chile's pharmaceutical framework sits within the Ministry of Health system. Pharmaceutical product applications are evaluated by the Instituto de Salud Pública de Chile (ISP).
Official ISP registration guidance ↗Sanitary registration is not a one-time filing
Renewals, modifications, safety interfaces and authority communications should be assigned before a portfolio becomes operational.
ISP information for industry ↗Unusual products require feasibility, not a generic diagnostic
Special substances, dosage forms or high-rejection pathways may justify a focused feasibility assessment before a normal filing scope is defined.
ISP exceptional authorization framework ↗Editorial principles
Specific enough to be useful. Careful enough to be trusted.
Authority pages, regulations and official documents support factual claims.
Information is separated from legal advice and authority decisions.
Registration, lifecycle, manufacturing, quality, procurement and industry structure.
Material regulatory guides show when they were published or revised.